Platform technology for cellular therapies
CSIRO’s IP is a platform technology for the rapid expansion of cells whilst maintaining phenotype. The technology will be useful for a wide range of cellular therapies and tissue engineering applications. (2 pages)
A video clip illustrating the process of growing fibroblast cells on to carbon nanotube yarns for possible applications in tissue engineering. (0:30)
Advances in biomedical materials are delivering products that promote human tissue repair, renewed growth and ability to monitor patient well-being.
Bioinformatics in health and medicine
Bioinformatics is about using mathematics, statistics and information technology to extract useful information from large and complex biological datasets.
Bioinformatics research at CSIRO enables advances in areas such as drug discovery and disease management.
Expansion of cells on basement membrane type substrate
CSIRO’s technology allows the rapid expansion of eukaryotic cells on a basement membrane type substrate whilst maintaining phenotype. The technology will be useful for a wide range of cellular therapies and tissue engineering applications.
Alternatives to antibiotics reduce animal disease
CSIRO researchers are developing vaccines and investigating other alternatives to in-feed antibiotics for livestock. These new products will improve animal health and welfare and reduce the risk of drug-resistant bacteria.
What foods give kids a healthy start to life?
An international symposium on the role nutrition plays in the prevention and management of pregnancy complications and early childhood diseases such as autism, asthma, obesity and cancer will be held in Adelaide this Friday, 30 July.
Influenza diagnosis and surveillance improved
An international workshop being held this week at CSIRO’s Australian Animal Health Laboratory (AAHL) in Geelong, Victoria, will lead to improved diagnosis and surveillance of animal influenza in the Asia Pacific region.
International recognition for a 'Living Treasure'
The first Chief of CSIRO Human Nutrition, Dr Basil Hetzel, has received the prestigious 2009 Pollin Prize for his research into the effects of iodine deficiency on brain developments in newborns.
Measuring molecules to improve drug design
CSIRO has patented an improved microscopy method for measuring the shapes and sizes of proteins which could help scientists create new pharmaceuticals that are a better match for the proteins they target.
Reducing bottlenecks in emergency departments
The Australian e-Health Research Centre has shown that it is possible to accurately predict how many patients will present at hospital emergency departments, their expected medical needs and the number of hospital admissions.
E-Health Centre joins Open Health Tools Foundation
The Australian E-Health Research Centre (AEHRC) – a joint venture between CSIRO and the Queensland Government – has joined an international organisation devoted to improving patient and care provider access to reliable medical information.
A$20 million for ICT innovation in healthcare
CSIRO today welcomed the launch of the Australian e-Health Research Centre (AEHRC) as a national venture, supported by A$20 million in funding from the Federal and Queensland governments.
Using biostatistics to detect disease outbreaks
An internationally recognised authority in biostatistics, Harvard University Professor Louise Ryan, is working with CSIRO researchers to help improve the way statistics are used to detect disease outbreaks in Australia.
Canadian expert joins Australian e-Health Centre
One of the major contributors to the development and implementation of Canada’s electronic health records system, Richard C Alvarez, has been appointed an Honorary Fellow of the Australian e-Health Research Centre in Brisbane.
ICT plugs into healthcare delivery
Advances in ICT (Information and Communication Technologies) for personal health care are playing a critical role in improving people's health and wellbeing.
Geelong scientist receives Eureka recognition
Geelong scientist, Dr Linfa Wang, was last night honoured as a Eureka Prize finalist, recognising his exceptional scientific research in discovering emerging viral diseases such as Severe Acute Respiratory Syndrome (SARS).